2023-08-02 16:55:12 ET
- Evolent Health press release ( NYSE: EVH ): Q2 Non-GAAP EPS of $0.14 misses by $0.01 .
- Revenue of $469.1M (+46.6% Y/Y) beats by $8.46M .
- For the three months ending September 30, 2023, revenue is expected to be in the range of approximately $500 million to $520 million.
- The Company is reiterating its previously-stated guidance for revenue for the year ending December 31, 2023, with revenue expected to be in the range of approximately $1.935 billion to $1.965 billion.
For further details see:
Evolent Health Non-GAAP EPS of $0.14 misses by $0.01, revenue of $469.1M beats by $8.46M